126 related articles for article (PubMed ID: 18057533)
1. Expression of MAGE-A12 in oral squamous cell carcinoma.
Mollaoglu N; Vairaktaris E; Nkenke E; Neukam FW; Ries J
Dis Markers; 2008; 24(1):27-32. PubMed ID: 18057533
[TBL] [Abstract][Full Text] [Related]
2. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
Ries J; Vairaktaris E; Mollaoglu N; Wiltfang J; Neukam FW; Nkenke E
J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
[TBL] [Abstract][Full Text] [Related]
3. A novel multiple-marker method for the early diagnosis of oral squamous cell carcinoma.
Ries J; Mollaoglu N; Toyoshima T; Vairaktaris E; Neukam FW; Ponader S; Nkenke E
Dis Markers; 2009; 27(2):75-84. PubMed ID: 19893202
[TBL] [Abstract][Full Text] [Related]
4. MAGE-A as a novel approach in the diagnostic accuracy of oral squamous cell cancer: a case report.
Metzler P; Mollaoglu N; Schwarz S; Neukam FW; Nkenke E; Ries J
Head Neck Oncol; 2009 Dec; 1():39. PubMed ID: 20015401
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic and therapeutic relevance of NY-ESO-1 expression in oral squamous cell carcinoma.
Ries J; Mollaoglu N; Vairaktaris E; Neukam FW; Nkenke E
Anticancer Res; 2009 Dec; 29(12):5125-30. PubMed ID: 20044626
[TBL] [Abstract][Full Text] [Related]
6. Aberrant promoter hypermethylation of the CHFR gene in oral squamous cell carcinomas.
Baba S; Hara A; Kato K; Long NK; Hatano Y; Kimura M; Okano Y; Yamada Y; Shibata T
Oncol Rep; 2009 Nov; 22(5):1173-9. PubMed ID: 19787237
[TBL] [Abstract][Full Text] [Related]
7. Cancer-testis gene expression profiling in esophageal squamous cell carcinoma: identification of specific tumor marker and potential targets for immunotherapy.
Forghanifard MM; Gholamin M; Farshchian M; Moaven O; Memar B; Forghani MN; Dadkhah E; Naseh H; Moghbeli M; Raeisossadati R; Abbaszadegan MR
Cancer Biol Ther; 2011 Aug; 12(3):191-7. PubMed ID: 21613820
[TBL] [Abstract][Full Text] [Related]
8. Prediction of recurrence using exfoliative cytology and melanoma-associated antigen-A mRNA analysis following wide excision of oral squamous cell carcinoma: short report.
Mollaoglu N; Metzler P; Zenk J; Nkenke E; Neukam FW; Ries J
Cytopathology; 2011 Dec; 22(6):387-91. PubMed ID: 21054590
[TBL] [Abstract][Full Text] [Related]
9. Investigation of the expression of melanoma antigen-encoding genes (MAGE-A1 to -A6) in oral squamous cell carcinomas to determine potential targets for gene-based cancer immunotherapy.
Ries J; Schultze-Mosgau S; Neukam F; Diebel E; Wiltfang J
Int J Oncol; 2005 Mar; 26(3):817-24. PubMed ID: 15703841
[TBL] [Abstract][Full Text] [Related]
10. Expression of MAGE-A1-A12 subgroups in the invasive tumor front and tumor center in oral squamous cell carcinoma.
Brisam M; Rauthe S; Hartmann S; Linz C; Brands RC; Kübler AC; Rosenwald A; Müller-Richter UD
Oncol Rep; 2016 Apr; 35(4):1979-86. PubMed ID: 26820613
[TBL] [Abstract][Full Text] [Related]
11. Expression of cytokeratin 17 mRNA in oral squamous cell carcinoma cells obtained by brush biopsy: preliminary results.
Toyoshima T; Koch F; Kaemmerer P; Vairaktaris E; Al-Nawas B; Wagner W
J Oral Pathol Med; 2009 Jul; 38(6):530-4. PubMed ID: 19222712
[TBL] [Abstract][Full Text] [Related]
12. Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.
Yin B; Zeng Y; Wang X; Liu G; Zhang M; Song Y
Int J Clin Exp Pathol; 2014; 7(7):4112-9. PubMed ID: 25120790
[TBL] [Abstract][Full Text] [Related]
13. [An effective biological marker to detect oral squamous cancer cells--expression patterns of CK 10, 17, 19 and SCCA mRNA--].
Yoshida Y
Kokubyo Gakkai Zasshi; 2007 Mar; 73(3)-74(1)():37-42. PubMed ID: 17722467
[TBL] [Abstract][Full Text] [Related]
14. The melanoma antigen gene as a surveillance marker for the detection of circulating tumor cells in patients with breast carcinoma.
Kwon S; Kang SH; Ro J; Jeon CH; Park JW; Lee ES
Cancer; 2005 Jul; 104(2):251-6. PubMed ID: 15937912
[TBL] [Abstract][Full Text] [Related]
15. A multimarker real-time RT-PCR for MAGE-A gene expression allows sensitive detection and quantification of the minimal systemic tumor load in patients with localized cancer.
Mecklenburg I; Weckermann D; Zippelius A; Schoberth A; Petersen S; Prang N; Riethmüller G; Kufer P
J Immunol Methods; 2007 Jun; 323(2):180-93. PubMed ID: 17540401
[TBL] [Abstract][Full Text] [Related]
16. ORAOV1 is amplified in oral squamous cell carcinoma.
Xavier FC; Rodini CO; Paiva KB; Destro MF; Severino P; Moyses RA; ; Tajara EH; Nunes FD
J Oral Pathol Med; 2012 Jan; 41(1):54-60. PubMed ID: 21623924
[TBL] [Abstract][Full Text] [Related]
17. The expression of EMP1 is downregulated in oral squamous cell carcinoma and possibly associated with tumour metastasis.
Zhang J; Cao W; Xu Q; Chen WT
J Clin Pathol; 2011 Jan; 64(1):25-9. PubMed ID: 20980531
[TBL] [Abstract][Full Text] [Related]
18. Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702-associated epitope MAGE-A12:170-178.
Bettinotti MP; Panelli MC; Ruppe E; Mocellin S; Phan GQ; White DE; Marincola FM
Int J Cancer; 2003 Jun; 105(2):210-6. PubMed ID: 12673681
[TBL] [Abstract][Full Text] [Related]
19. Expression of cancer-testis antigens MAGE-A4 and MAGE-C1 in oral squamous cell carcinoma.
Montoro JR; Mamede RC; Neder Serafini L; Saggioro FP; Figueiredo DL; Silva WA; Jungbluth AA; Spagnoli GC; Zago MA
Head Neck; 2012 Aug; 34(8):1123-8. PubMed ID: 22083937
[TBL] [Abstract][Full Text] [Related]
20. The expression of MAGE and GAGE genes in uterine cervical carcinoma of Korea by RT-PCR with common primers.
Chang HK; Park J; Kim W; Kim K; Lee M; Park U; Choi B
Gynecol Oncol; 2005 May; 97(2):342-7. PubMed ID: 15863128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
